New Australian Cancer Research Facility to Profile 70K Tumor Proteomes Over Next Seven Years | GenomeWeb

NEW YORK (GenomeWeb) – The newly established Australian Cancer Research Foundation International Centre for the Proteome of Cancer (ProCan) has announced plans to generate proteomic profiles of roughly 70,000 cancer tumor samples over the next seven years.

Funded by $10 million in seed money from the Australian Cancer Research Foundation, Sydney-based ProCan is working with Sciex to acquire a suite of mass spec instruments to build what Phil Robinson, co-head of the center, called an "industrialized proteomics" lab.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.